Varenicline Blocks  2*-nAChR-Mediated Response and Activates  4*-nAChR-Mediated Responses in Mice In Vivo

Electrophysiological Perspectives on the Therapeutic Use of Nicotinic Acetylcholine Receptor Partial Agonists

(2011) R. L. Papke et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Pre-clinical properties of the α4β2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence

(2010) H Rollema et al.   BRITISH JOURNAL OF PHARMACOLOGY

The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: Differences in α4β2 nicotinic receptor activation

(2010) Colin S. Cunningham et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Activation and Inhibition of Mouse Muscle and Neuronal Nicotinic Acetylcholine Receptors Expressed in Xenopus Oocytes

(2010) R. L. Papke et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Nicotinic Partial Agonists Varenicline and Sazetidine-A Have Differential Effects on Affective Behavior

(2010) J. R. Turner et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Acetylcholine Receptor (AChR)  5 Subunit Variant Associated with Risk for Nicotine Dependence and Lung Cancer Reduces ( 4 2)2 5 AChR Function

(2010) A. Kuryatov et al.   MOLECULAR PHARMACOLOGY

Structural differences determine the relative selectivity of nicotinic compounds for native α4β2*-, α6β2*-, α3β4*- and α7-nicotine acetylcholine receptors

(2010) Sharon R. Grady et al.   NEUROPHARMACOLOGY

Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis

(2010) Yann S. Mineur et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Preclinical pharmacology of the α4β2 nAChR partial agonist varenicline related to effects on reward, mood and cognition

(2009) Hans Rollema et al.   BIOCHEMICAL PHARMACOLOGY

In vivo effects of 3-iodocytisine: Pharmacological and genetic analysis of hypothermia and evaluation of chronic treatment on nicotinic binding sites

(2009) C.A. Zambrano et al.   NEUROPHARMACOLOGY

Effect of the α4β2∗ nicotinic acetylcholine receptor partial agonist varenicline on dopamine release in β2 knock-out mice with selective re-expression of the β2 subunit in the ventral tegmental area

(2009) Christelle Reperant et al.   NEUROPHARMACOLOGY

Central 5-HT3 receptor-induced hypothermia in mice: Interstrain differences and comparison with hypothermia mediated via 5-HT1A receptor

(2009) Vladimir S. Naumenko et al.   NEUROSCIENCE LETTERS

Ondansetron and fluoxetine reduce sleep apnea in mice lacking monoamine oxidase A

(2009) C. Real et al.   RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY

Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice.

(2008) Jonathan D. Raybuck et al.   BEHAVIORAL NEUROSCIENCE

Effect of varenicline on the acute and repeated locomotor responses to nicotine in rats

(2008) Magdalena Zaniewska et al.   SYNAPSE

Synthesis, nicotinic acetylcholine receptor binding, and pharmacological properties of 3′-(substituted phenyl)deschloroepibatidine analogs

(2007) F. Ivy Carroll et al.   BIOORGANIC & MEDICINAL CHEMISTRY